bupivacaine has been researched along with resiniferatoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, EL; Bright, CA; Kissin, I | 1 |
| Berta, T; Decosterd, I; Gao, YJ; Ji, RR; Suter, MR | 1 |
2 other study(ies) available for bupivacaine and resiniferatoxin
| Article | Year |
|---|---|
Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivity.
Topics: Animals; Bupivacaine; Capsaicin; Carrageenan; Diterpenes; Hyperalgesia; Male; Nerve Block; Peripheral Nerves; Rats; Rats, Sprague-Dawley | 2002 |
Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.
Topics: Animals; Bromodeoxyuridine; Bupivacaine; Diterpenes; Enzyme Activation; Hot Temperature; Microglia; Microspheres; Motor Activity; Nerve Block; Nerve Fibers; Nociceptors; p38 Mitogen-Activated Protein Kinases; Pain; Phosphorylation; Proprioception; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves | 2009 |